0001181431-12-042132.txt : 20120725 0001181431-12-042132.hdr.sgml : 20120725 20120725181611 ACCESSION NUMBER: 0001181431-12-042132 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120529 FILED AS OF DATE: 20120725 DATE AS OF CHANGE: 20120725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gionco David CENTRAL INDEX KEY: 0001456864 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12979717 MAIL ADDRESS: STREET 1: 9 HOWELL DRIVE CITY: FAR HILLS STATE: NJ ZIP: 07931 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd351641.xml X0206 3 2012-05-29 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001456864 Gionco David SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 Group VP & Chief Acct Officer Common Stock, $.01 par value 53488 D Option to Purchase Common Stock, $.01 par value 4.32 2010-06-26 2016-06-26 Common Stock, $.01 par value 7500 D Option to Purchase Common Stock, $.01 par value 4.53 2012-12-19 2018-12-19 Common Stock, $.01 par value 26000 D Option to Purchase Common Stock, $.01 par value 5.27 2013-02-19 2019-02-19 Common Stock, $.01 par value 60000 D Option to Purchase Common Stock, $.01 par value 13.81 2010-09-14 2019-11-22 Common Stock, $.01 par value 14582 D Option to Purchase Common Stock, $.01 par value 9.63 2013-02-22 2021-02-22 Common Stock, $.01 par value 60000 D These options are fully vested and exercisable. 19,500 of these options are fully vested and exercisable and 6,500 of these options will vest on December 19, 2012. 45,000 of these options are fully vested and exercisable and 15,000 of these options will vest on February 19, 2013. 15,000 of these options are fully vested and exercisable and 15,000 of these options will vest on each of February 22, 2013, February 22, 2014 and February 22, 2015. Irina Ishak as Attorney-in-Fact for David Gionco 2012-07-25